BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19784796)

  • 21. Higher reliability of 18F-FDG target background ratio compared to standardized uptake value in vulnerable carotid plaque detection: a pilot study.
    Niccoli Asabella A; Ciccone MM; Cortese F; Scicchitano P; Gesualdo M; Zito A; Di Palo A; Angiletta D; Regina G; Marzullo A; Rubini G
    Ann Nucl Med; 2014 Jul; 28(6):571-9. PubMed ID: 24737136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of atorvastatin on atherosclerotic plaque formation and platelet activation in hypercholesterolemic rats.
    Gocmen AY; Ocak GA; Ozbilim G; Delibas N; Gumuslu S
    Can J Physiol Pharmacol; 2013 Sep; 91(9):680-5. PubMed ID: 23984971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring of atherosclerosis evolution by detection of inflammatory states of aortae in a rabbit model using 18F-FDG -PET/CT.
    Zhao QM; Zhao X; Feng TT; Zhang MD; Zhuang XC; Zhao XC; Zhang XX; Su G
    Q J Nucl Med Mol Imaging; 2014 Dec; 58(4):440-50. PubMed ID: 24518191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of atorvastatin therapy on oxidant-antioxidant status and atherosclerotic plaque formation.
    Sezer ED; Sozmen EY; Nart D; Onat T
    Vasc Health Risk Manag; 2011; 7():333-43. PubMed ID: 21731885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of 18F-fluoro-deoxy-glucose, 18F-fluoro-methyl-choline, and 18F-DPA714 for positron-emission tomography imaging of leukocyte accumulation in the aortic wall of experimental abdominal aneurysms.
    Sarda-Mantel L; Alsac JM; Boisgard R; Hervatin F; Montravers F; Tavitian B; Michel JB; Le Guludec D
    J Vasc Surg; 2012 Sep; 56(3):765-73. PubMed ID: 22726755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of inflamed atherosclerotic lesions in vivo using PET-CT.
    Jezovnik MK; Zidar N; Lezaic L; Gersak B; Poredos P
    Inflammation; 2014 Apr; 37(2):426-34. PubMed ID: 24282108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo non-invasive serial monitoring of FDG-PET progression and regression in a rabbit model of atherosclerosis.
    Worthley SG; Zhang ZY; Machac J; Helft G; Tang C; Liew GY; Zaman AG; Worthley MI; Fayad ZA; Buchsbaum MS; Fuster V; Badimon JJ
    Int J Cardiovasc Imaging; 2009 Mar; 25(3):251-7. PubMed ID: 18979182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT).
    Mehta NN; Torigian DA; Gelfand JM; Saboury B; Alavi A
    J Vis Exp; 2012 May; (63):e3777. PubMed ID: 22588186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT.
    Hetterich H; Rominger A; Walter L; Habs M; Volpers S; Hacker M; Reiser MF; Bartenstein P; Saam T
    Int J Cardiovasc Imaging; 2016 Jan; 32(1):49-59. PubMed ID: 25898891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pilot trial to examine the effect of high-dose niacin on arterial wall inflammation using fluorodeoxyglucose positron emission tomography.
    deGoma EM; Salavati A; Shinohara RT; Saboury B; Pollan L; Schoen M; Torigian DA; Mohler ER; Dunbar RL; Litt HI; Woo J; Rader DJ; Alavi A; Mehta NN
    Acad Radiol; 2015 May; 22(5):600-9. PubMed ID: 25708866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High resolution FDG-microPET of carotid atherosclerosis: plaque components underlying enhanced FDG uptake.
    Liu J; Kerwin WS; Caldwell JH; Ferguson MS; Hippe DS; Alessio AM; Martinez-Malo V; Pimentel K; Miyaoka RS; Kohler TR; Hatsukami TS; Yuan C
    Int J Cardiovasc Imaging; 2016 Jan; 32(1):145-52. PubMed ID: 26280889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of atorvastatin on the expression of gamma-glutamyl transferase in aortic atherosclerotic plaques of apolipoprotein E-knockout mice.
    Li G; Wu XW; Lu WH; Ai R; Chen F; Tang ZZ
    BMC Cardiovasc Disord; 2014 Oct; 14():145. PubMed ID: 25326709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE*3-Leiden.CETP mice.
    Berbée JF; Wong MC; Wang Y; van der Hoorn JW; Khedoe PP; van Klinken JB; Mol IM; Hiemstra PS; Tsikas D; Romijn JA; Havekes LM; Princen HM; Rensen PC
    J Nutr Biochem; 2013 Aug; 24(8):1423-30. PubMed ID: 23337345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PET imaging of inflammation in atherosclerosis.
    Tarkin JM; Joshi FR; Rudd JH
    Nat Rev Cardiol; 2014 Aug; 11(8):443-57. PubMed ID: 24913061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Imaging of Inflammation in a Mouse Model of Atherosclerosis Using a Zirconium-89-Labeled Probe.
    Ahmed M; Tegnebratt T; Tran TA; Lu L; Damberg P; GisterÄ A; Tarnawski L; Bone D; Hedin U; Eriksson P; Holmin S; Gustafsson B; Caidahl K
    Int J Nanomedicine; 2020; 15():6137-6152. PubMed ID: 32884268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monitoring of macrophage accumulation in statin-treated atherosclerotic mouse model using sodium iodide symporter imaging system.
    Yoo RJ; Kim MH; Woo SK; Kim KI; Lee TS; Choi YK; Kang JH; Lim SM; Lee YJ
    Nucl Med Biol; 2017 May; 48():45-51. PubMed ID: 28208058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atorvastatin Promotes Macrocalcification, But Not Microcalcification in Atherosclerotic Rabbits: An 18F-NaF PET/CT Study.
    Zhang X; Chen X; Liang Z; Nie M; Yan Y; Zhao Q
    J Cardiovasc Pharmacol; 2021 Oct; 78(4):544-550. PubMed ID: 34651601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of 3-month atorvastatin therapy on arterial inflammation, calcification, abdominal adipose tissue and circulating biomarkers.
    Wu YW; Kao HL; Huang CL; Chen MF; Lin LY; Wang YC; Lin YH; Lin HJ; Tzen KY; Yen RF; Chi YC; Huang PJ; Yang WS
    Eur J Nucl Med Mol Imaging; 2012 Mar; 39(3):399-407. PubMed ID: 22109668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variability and uncertainty of 18F-FDG PET imaging protocols for assessing inflammation in atherosclerosis: suggestions for improvement.
    Huet P; Burg S; Le Guludec D; Hyafil F; Buvat I
    J Nucl Med; 2015 Apr; 56(4):552-9. PubMed ID: 25722452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atherosclerotic inflammatory activity in the aorta and its correlation with aging and gender as assessed by 18F-FDG-PET.
    Bural GG; Torigian DA; Basu S; Bozkurt MF; Houseni M; Alavi A
    Hell J Nucl Med; 2013; 16(3):164-8. PubMed ID: 24137578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.